IM Cannabis Corp. current report, Q2 FY2023

IM Cannabis Corp. Form 6-K Summary

Business Context and Reporting Period

IM Cannabis Corp., an Israeli foreign private issuer, filed Form 6-K for May 2023 on May 15, 2023. The filing furnishes interim financial information and management commentary for the three months ended March 31, 2023.

  • Principal executive offices: Kibbutz Glil Yam, Central District, Israel.
  • The company files annual reports on Form 20-F.
  • Reporting period: quarter ended March 31, 2023.

Financial Metrics

The filing index identifies interim consolidated financial statements and management’s discussion and analysis for the quarter ended March 31, 2023, but the provided filing text does not include their contents. Revenue, profit or loss, cash flow, margins, debt, liquidity, and other financial metrics cannot be determined from the supplied text.

Material Changes Versus the Prior Comparable Period

The provided text does not describe changes versus the three months ended March 31, 2022 or any other prior comparable period.

Guidance, Outlook, Risks, Contingencies, and Unusual Items

The supplied text does not provide guidance, outlook commentary, risk disclosures, contingencies, or descriptions of unusual items. These matters may be addressed in the referenced exhibits, particularly Exhibit 99.3, but the exhibit contents were not provided.

Important Facts for Investors to Verify

  • Review Exhibit 99.2 for quarterly revenue, profitability, cash flow, balance-sheet, debt, liquidity, and going-concern information.
  • Review Exhibit 99.3 for management’s explanations of operating results, material changes, liquidity, risks, and outlook.
  • Verify year-over-year and sequential trends using the complete interim financial statements.
  • Confirm any non-GAAP measures, cannabis-industry operating metrics, financing activities, and subsequent events disclosed in the exhibits.